http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-90912-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2006-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f81e663de60545e072a2ff36c2fdf16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b87ab051a2d451299cedd63a826dcf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c485608534eca5d67ed1bdec00c781fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04241c57d772e7827009024da27ea5eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4ea760b854cae5feb0c2ebdf3662222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ea9b2df9e8790d76137519558b4a7f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f622b92add7488650d7b26442dd65bee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42c08c7987994a3e92daa6a7d4cdbc9e
publicationDate 2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-90912-C2
titleOfInvention CGRP-ANTAGONISTS, THE METHOD OF THEIR PREPARATION, AND THEIR APPLICATION AS MEDICINAL PRODUCTS
abstract The application describes CGRP antagonists of General formula (I), (I) in which R, R, R and R have the values indicated in claim 1, their tautomers, their isomers, their diastereomers, their enantiomers, their hydrates, their mixtures and salts thereof, as well as hydrates of salts, especially their physiologically compatible salts with inorganic or organic acids, including those compounds of general formula I in which one or more hydrogen atoms are substituted for deuterium, drugs containing these compounds, their use and [The application describes CGRP antagonists of General formula (I), (I) in otori R, R, R and R have the meanings indicated in claim 1, their tautomers, their isomers, their diastereomers, their enantiomers, their hydrates, their mixtures and their salts, as well as their hydrates, especially their physiologically compatible salts with inorganic or organic acids, including those compounds of general formula I in which one or more hydrogen atoms are replaced by deuterium, medicaments that contain these compounds, their use, and the process for their preparation.
priorityDate 2005-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559591

Total number of triples: 22.